Back to results
US 2019/0103187 A1Published application
Method of detecting fetal chromosomal aneuploidy
AssigneeTheragen Genomecare Co., Ltd.
InventorsSun Shin KIM, Myung Jun JEONG, Kyung Tae MIN, Min Ae AN, Jung Su HA, So Ra LEE, Jin Han BAE, Hee Jae JOO
Life of this patent
Estimating the term…
Abstract
Provided are a method of detecting chromosomal aneuploidy of a targeted fetal chromosome, and a computer-readable medium having recorded thereon a program to be applied to performing the method. According to the present disclosure, fetal chromosomal aneuploidy may be non-invasively and prenatally diagnosed with excellent sensitivity and specificity.
Claims20
A method of detecting chromosomal aneuploidy of a target fetal chromosome, the method comprising:
- obtaining sequence information (reads) of a plurality of nucleic acid fragments obtained from a biological sample of a pregnant woman;
- mapping the obtained reads to a reference human genome to assign the reads of the nucleic acid fragments to the chromosome;
- calculating a GC content and a fraction of reads (Rf) of the nucleic acid fragments on the target chromosome to the number of the nucleic acid fragments, based on the reads of the nucleic acid fragments assigned to the chromosome;
- selecting adaptive reference samples belonging to a shared range of unit values of Rf and unit values of GC content from reference samples, based on the calculated Rf and GC content on the target chromosome;
- calculating z scores of a verification reference samples and z scores of the test samples using the selected adaptive reference samples;
- and
- determining that the target chromosome has chromosomal aneuploidy when, by comparing the calculated z scores of the verification reference samples with the z scores of the test samples, the z scores of the test samples are larger than the z scores of the verification reference samples.
4 more elements
Dependencies are inferred from the claim text.